Related Experiment Video
Updated: Dec 30, 2025

09:02
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
3.0K
Bifunctional RNA-Targeting Deoxyribozyme Nanodevice as a Potential Theranostic Agent
Aleksandr A Spelkov1, Ekaterina A Goncharova1, Artemii M Savin1
1Laboratory of Solution Chemistry of Advanced Materials, and Technologies, ITMO University, Lomonosova St. 9, 191002, St. Petersburg, Russian Federation.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|January 17, 2020
Summary
Researchers developed a DNA nanodevice for simultaneous RNA detection and cleavage. This innovation offers a new platform for targeted diagnostics and therapies for various diseases.
Area of Science:
- Biotechnology
- Molecular Biology
- Nanotechnology
Background:
- Theranostics combine disease diagnosis and therapy.
- Developing precise tools for simultaneous detection and treatment is crucial.
Purpose of the Study:
- To design a DNA nanodevice capable of simultaneous RNA target detection and cleavage.
- To achieve high selectivity in RNA recognition under physiological conditions.
Main Methods:
- Design and synthesis of a novel DNA nanodevice.
- Testing the nanodevice's ability to detect and cleave a specific RNA target.
- Evaluating the selectivity and performance under near physiological conditions.
Main Results:
- The DNA nanodevice successfully reported the presence of the RNA target via increased fluorescence.
- The nanodevice effectively cleaved the targeted RNA.
- High selectivity for RNA target recognition was demonstrated under near physiological conditions.
Conclusions:
- The developed DNA nanodevice functions as a theranostic tool.
- This approach provides a foundation for creating DNA nanomachines for diagnostics and therapy.
- Potential applications include treating viral infections, cancer, and genetic disorders.
Related Concept Videos
siRNA - Small Interfering RNAs
18.2K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.2K
Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Ribozymes
13.2K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
13.2K
RNA Interference
27.6K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.6K

